Oxford Instruments EBIT per Share
The EBIT per Share of Oxford Instruments (OXIG.L) as of Jul 25, 2026 is 1.25 GBP. In the previous year, EBIT per Share was 1.04 GBP — a change of 19.96% (higher).
Get this data via API
Financial Data API
EBIT per Share
1.25GBP
YoY
19.96%
Last updated:
EBIT per Share of Oxford Instruments is 2026 1.25 GBP. EBIT per Share of Oxford Instruments was 2025 1.04 GBP. It decreases by 19.96% higher compared to the previous year.
Access this data via the Eulerpool API
Oxford Instruments Stock analysis
What does Oxford Instruments do? Oxford Instruments PLC was founded in Oxford, United Kingdom in 1959. Today, the company is a global provider of solutions for scientific and industrial applications. Its goal is to combine leading technologies and capabilities to meet the constantly changing needs of customers.
Oxford Instruments' business model encompasses four main divisions: research and development, industrial analysis, semiconductor technology, and magnetic resonance. In the research and development division, technologies for material characterization and analysis are developed, focusing on areas such as surface analysis, particle characterization, magnetism, electronics, and superconductivity. These technologies are primarily used for research and development in fields such as semiconductor and nanotechnology.
The industrial analysis division focuses on developing instruments and solutions for material characterization and process monitoring in a variety of industries. Oxford Instruments offers material analysis devices for the pharmaceutical industry, microscopes and analytical instruments for electronics production, and solutions for food production and metallurgy, among others.
Oxford Instruments' semiconductor division develops technologies and solutions for wafer production and integration of semiconductor components in electronic devices. The company produces process solutions for working with semiconductor materials such as silicon, gallium arsenide, indium phosphide, and gallium nitride.
Lastly, Oxford Instruments has a business unit for magnetic resonance technology, specializing in the manufacture of machines for magnetic resonance imaging (MRI). These devices are used in medical diagnostics as well as research and development in biology, chemistry, and material science.
In addition to these four main divisions, Oxford Instruments also offers a variety of products. For example, cryogenic probe technology allows for the examination of materials at very low temperatures. Another innovation is laser ablation technology, which enables the manipulation of materials on a microscopic level, such as creating special surfaces or producing tiny circuits in semiconductors.
In 2019, Oxford Instruments completed the acquisition of American company Asylum Research, a leading provider of atomic force microscopy (AFM). This expanded the company's portfolio in the area of material characterization and research.
Oxford Instruments employs over 2,500 people worldwide and serves customers in over 50 countries. The company is committed to meeting the growing requirements of its customers and contributing to important advancements in science and research through its technological innovations and solutions. Oxford Instruments is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Oxford Instruments stock
EBIT per Share of Oxford Instruments is 1.25 GBP in 2026.
Access this data via the Eulerpool API
Income Statement — Oxford Instruments
All Key Metrics — Oxford Instruments
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth